Literature DB >> 24307729

Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.

María Ferez1, Mario Castro, Balbino Alarcon, Hisse M van Santen.   

Abstract

Antigenic T cell stimulation requires interaction between the TCR of the T cell and cognate peptide-MHC molecules presented by the APC. Although studies with TCR-specific Abs and soluble peptide-MHC ligands have shown that the TCR needs to be crosslinked by two or more ligands to induce T cell stimulation, it is not understood how several MHC molecules loaded with the cognate antigenic peptide can produce crosslinking under physiological conditions. We show at the molecular level that large clusters of cognate peptide-MHC are formed at the surface of murine professional and nonprofessional APCs upon virus infection and that these clusters impinge on the stimulatory capacity of the APC. These clusters are formed by tight apposition of cognate peptide-MHC complexes in a configuration that is compatible with simultaneous engagement of two or more TCRs. This suggests that physiological expression of Ag allows formation of multivalent ligands for the TCR that permit TCR crosslinking and T cell activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307729     DOI: 10.4049/jimmunol.1301224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Lymphocyte repertoire selection and intracellular self/non-self-discrimination: historical overview.

Authors:  Donald R Forsdyke
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

2.  Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses.

Authors:  Nadia Anikeeva; Nicholas O Fischer; Craig D Blanchette; Yuri Sykulev
Journal:  J Immunol       Date:  2018-12-12       Impact factor: 5.422

3.  Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation.

Authors:  Jeff D Colbert; Freidrich M Cruz; Christina E Baer; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

Review 4.  Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface.

Authors:  Fernando M Ruggiero; Sebastian Springer
Journal:  Curr Res Immunol       Date:  2022-05-23

Review 5.  Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.

Authors:  Luis C Antón; Jonathan W Yewdell
Journal:  J Leukoc Biol       Date:  2014-02-14       Impact factor: 4.962

Review 6.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Authors:  Devin Dersh; Jaroslav Hollý; Jonathan W Yewdell
Journal:  Nat Rev Immunol       Date:  2020-08-20       Impact factor: 53.106

Review 7.  Organizing MHC Class II Presentation.

Authors:  David R Fooksman
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

Review 8.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06

Review 9.  Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms.

Authors:  Mario Castro; Hisse M van Santen; María Férez; Balbino Alarcón; Grant Lythe; Carmen Molina-París
Journal:  Front Immunol       Date:  2014-04-30       Impact factor: 7.561

10.  Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.

Authors:  John W Hickey; Fernando P Vicente; Gregory P Howard; Hai-Quan Mao; Jonathan P Schneck
Journal:  Nano Lett       Date:  2017-10-10       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.